Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Thiruvengadam Arumugam

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5034589904. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2011: 1 paper · 2012: 4 papers · 2013: 1 paper · 2014: 4 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 15

  1. Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo. Co-author DOI 10.1016/j.pan.2020.12.008↗
  2. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scitranslmed.aat3487↗
  3. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo. Co-author DOI 10.1159/000445664↗
  4. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. First author DOI 10.1152/ajpgi.00169.2015↗
  5. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.1371/journal.pone.0144969↗
  6. Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. Co-author DOI 10.1016/j.canlet.2014.04.016↗
  7. Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts. Co-author DOI 10.1016/j.nucmedbio.2014.08.001↗
  8. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Co-author DOI 10.1038/srep04410↗
  9. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-14-0028↗
  10. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Co-author DOI 10.1158/1535-7163.mct-12-0771↗
  11. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Co-author DOI 10.1053/j.gastro.2012.08.044↗
  12. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Co-author DOI 10.1136/gutjnl-2011-300544↗
  13. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Co-author DOI 10.1158/1541-7786.mcr-12-0022↗
  14. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0040420↗
  15. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Co-author DOI 10.1097/mpa.0b013e31821f6927↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Craig D. Logsdon · 14 shared papers, 2011–2021 · strength 0.68
  2. Vijaya Ramachandran · 8 shared papers, 2011–2018 · strength 0.38
  3. Baoan Ji · 3 shared papers, 2012–2021 · strength 0.17
  4. Rosa F. Hwang · 4 shared papers, 2011–2018 · strength 0.15
  5. Huamin Wang · 3 shared papers, 2012–2018 · strength 0.13
  6. Jia Cao · 2 shared papers, 2015–2016 · strength 0.11
  7. Lu Zhuang · 1 shared paper, 2021 · strength 0.11
  8. Zhaoshen Li · 1 shared paper, 2021 · strength 0.11
  9. Haojie Huang · 1 shared paper, 2021 · strength 0.11
  10. Lisi Peng · 1 shared paper, 2021 · strength 0.11
  11. Hui Jiang · 1 shared paper, 2021 · strength 0.11
  12. Zobeida Cruz‐Monserrate · 3 shared papers, 2012–2014 · strength 0.11
  13. Liran Zhou · 1 shared paper, 2018 · strength 0.06
  14. Jianhua Ling · 1 shared paper, 2018 · strength 0.06
  15. Yan Liu · 1 shared paper, 2018 · strength 0.06
  16. Paul J. Chiao · 1 shared paper, 2018 · strength 0.06
  17. Anirban Maitra · 1 shared paper, 2018 · strength 0.06
  18. Mien‐Chie Hung · 1 shared paper, 2018 · strength 0.06
  19. Jeffrey E. Lee · 1 shared paper, 2018 · strength 0.06
  20. Michael A. Curran · 1 shared paper, 2018 · strength 0.06
  21. Jia-Chun Yang · 1 shared paper, 2015 · strength 0.05
  22. Zhao‐Shen Li · 1 shared paper, 2015 · strength 0.05
  23. Leiming Xu · 1 shared paper, 2015 · strength 0.05
  24. Louis De Palatis · 1 shared paper, 2014 · strength 0.05
  25. Vincenzo Paolillo · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.